
    
      OBJECTIVES: I. Compare the efficacy of mitomycin vs. porfiromycin as an adjunct to
      radiotherapy for the treatment of epidermoid carcinomas of the head and neck.

      OUTLINE: Randomized study. Arm I: Radiotherapy plus Single-Agent Chemotherapy. Irradiation of
      involved head and neck sites by external-beam radiotherapy (EBRT) alone (source not
      specified), brachytherapy alone (using permanent or removable radiation sources), or both;
      plus Mitomycin, MITO, NSC-26980. Arm II: Radiotherapy plus Single-Agent Chemotherapy.
      Radiotherapy as in Arm I; plus Porfiromycin, NSC-56410.

      PROJECTED ACCRUAL: Approximately 200 patients will be entered over 3-4 years.
    
  